Research ArticleOriginal Article
Open Access

Antibodies against human platelet alloantigens and human leucocyte antigen class 1 in Saudi Arabian multiparous women and multi-transfused patients

Sarah K. Al-Ouda, Abdulmajeed A. Al-Banyan, Farjah H. Al-Gahtani, Abdel-Galil M. Abdel-Gader and Lateefa O. Al-Dakhil
Saudi Medical Journal June 2015, 36 (6) 665-670; DOI: https://doi.org/10.15537/smj.2015.6.11153

References

  1. ↵
    1. Bub CB,
    2. Martinelli BM,
    3. Avelino TM,
    4. Gonçalez AC,
    5. Barjas-Castro M de L,
    6. Castro V
    (2013) Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness. Rev Bras Hematol Hemoter 35:252–255.
    OpenUrl
  2. ↵
    1. Mandelbaum M,
    2. Koren D,
    3. Eichelberger B,
    4. Auerbach L,
    5. Panzer S
    (2005) Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization. Vox Sang 89:39–43.
    OpenUrlPubMed
  3. ↵
    1. Boehlen F,
    2. Bulla O,
    3. Michel M,
    4. Reber G,
    5. de Moerloose P
    (2003) HPA genotyping and antiplatelet antibodies in female blood donors. Hematol J 4:441–444.
    OpenUrlPubMed
  4. ↵
    1. Schnaidt M,
    2. Wernet D
    (2000) Platelet–specific antibodies in female blood donors after pregnancy. Trans Med 10:77–80.
    OpenUrlPubMed
  5. ↵
    1. Heal JM,
    2. Blumberg N
    (2004) Optimizing platelet transfusion therapy. Blood Rev 18:149–165.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Sarkar RS,
    2. Philip J,
    3. Jain N
    (2015) Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) technique and its correlation to platelet refractoriness in multi platelet concentrate transfused patients. Indian J Hematol Blood Transfus 31:77–84.
    OpenUrl
  7. ↵
    1. Kiefel V,
    2. König C,
    3. Kroll H,
    4. Santoso S
    (2001) Platelet alloantibodies in transfused patients. Transfusion 41:766–770.
    OpenUrlCrossRef
  8. ↵
    1. Al-Sheikh I,
    2. Rahi A,
    3. al-Khalifa M
    (2000) Genotyping human platelet alloantigens (HPA 1-5) in Saudis from Eastern Province, Saudi Arabia. East Mediterr Health J 6:168–175.
    OpenUrlPubMed
  9. ↵
    1. Radder CM,
    2. Brand A,
    3. Kanhai HH
    (2001) A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 185:683–688.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Bertrand G,
    2. Martageix C,
    3. Jallu V,
    4. Vitry F,
    5. Kaplan C
    (2006) Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 4:628–637.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Metcalfe P
    (2004) Platelet antigens and antibody detection. Vox Sang 87(Suppl 1):82–86.
    OpenUrlPubMed
  12. ↵
    1. Forestier F,
    2. Hohlfeld P
    (1998) Management of fetal and neonatal alloimmune thrombocytopenia. Biol Neonate 74:395–401.
    OpenUrlCrossRefPubMedWeb of Science
    1. Landau M,
    2. Rosenberg N
    (2011) Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. Transfusion 51:558–569.
    OpenUrl
  14. ↵
    1. Kaplan C,
    2. Morel-Kopp MC,
    3. Kroll H,
    4. Kiefel V,
    5. Schlegel N,
    6. Chesnel N,
    7. Mueller-Eckhardt C
    (1991) HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 78:425–429.
    OpenUrlPubMedWeb of Science
  15. ↵
    1. Jeremiah Z,
    2. Oburu J
    (2011) Survey of platelet glycoprotein specific antibodies and HLA class1 antibodies in a cross section of Nigerian multiparous women. International Journal of Blood Transfusion and Immunohematology 1:7–11.
    OpenUrl
    1. Skouri H,
    2. Gandouz R,
    3. Kraiem I,
    4. Dridi H,
    5. Bibi M,
    6. Khairi H,
    7. et al.
    (2009) Platelet specific alloantigens and antibodies in Tunisian women after three or more pregnancies. Transfus Med 19:269–273.
    OpenUrlPubMed
  17. ↵
    1. Panzer S,
    2. Auerbach L,
    3. Cechova E,
    4. Fischer G,
    5. Holensteiner A,
    6. Kitl EM,
    7. et al.
    (1995) Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol 90:655–660.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Kerkhoffs JL,
    2. Eikenboom JC,
    3. Schipperus MS,
    4. van Wordragen-Vlaswinkel RJ,
    5. Brand R,
    6. et al.
    (2006) A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 108:3210–3215.
    OpenUrlAbstract/FREE Full Text
    1. Song EY,
    2. Kini SM,
    3. Kim BC,
    4. Han KS,
    5. Park MH
    (2000) Positive rate of HLA Class I antibodies in multiparous Korean women. The Korean Journal of Laboratory Medicine 20:210–214.
    OpenUrl
    1. Pitchappan RM,
    2. Amutha S,
    3. Mahendran V,
    4. Brahmajothi V,
    5. Shankar Kumar U,
    6. Balakrishnan K,
    7. et al.
    (1993) Frequency of HLA antibodies in South India. Journal of Biosciences 18:373–380.
    OpenUrlCrossRef
    1. Rodey GE,
    2. Anderson J,
    3. Aster RH
    Acquisition of HLA lymphocytotoxic antibodies; NIAID Manual of tissue typing techniques. Publications No. 80-545 186 (U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, USA) 1979.
    1. Décary F,
    2. van Helden-Henningheim L,
    3. van Griethuysen D,
    4. Helmerhorst FM,
    5. van der Werf AJ,
    6. Engelfriet CP
    (1979) Detection of B-cell-specific alloantibodies in pregnancy sera in the lymphocytotoxicity and the indirect immunofluorescence techniques. Tissue Antigens 14:1–9.
    OpenUrlPubMed
    1. Simonney N,
    2. Layrisse Z,
    3. Balbas O,
    4. García E,
    5. Stoikow Z
    (1984) Cytotoxic antibodies in sera of Venezuelan multiparous women of Amerindian and mixed ethnic origin. Tissue Antigens 23:117–126.
    OpenUrlPubMed
    1. Friedman DF,
    2. Lukas MB,
    3. Jawad A,
    4. Larson PJ,
    5. Ohene-Frempong K,
    6. Manno CS
    (1996) Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood 88:3216–3222.
    OpenUrlAbstract/FREE Full Text
    1. Economidou J,
    2. Constantoulakis M,
    3. Augoustaki O,
    4. Adinolfi M
    (1971) Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 20:252–258.
    OpenUrlCrossRefPubMedWeb of Science
    1. Ferreira A,
    2. Zulli R,
    3. Soares S,
    4. De Castro V,
    5. Souza H
    (2011) Identification of platelet refractoriness in oncohematologic patients. Clinics 66:35–40.
    OpenUrl
    1. Kurz M,
    2. Greinix H,
    3. Hocker P,
    4. Kalhs P,
    5. Knobl P,
    6. Mayr WR
    (1996) Specificities of antiplatelet antibodies in multi-transfused patients with haemato-oncological disorders. Br J Haematol 95:564–569.
    OpenUrlPubMed
    1. Chuansumrit A,
    2. Nathalang O,
    3. Wangruangsathit S,
    4. Hathirat P,
    5. Chiewsilp P,
    6. Isarangkura1 P
    (2001) HLA alloimmunization in patients receiving multitransfusions of red blood cells. Southeast Asian J Trop Med Public Health 32:419–424.
    OpenUrlPubMed
    1. Chhay S,
    2. Vazifdar G,
    3. Rajadhyaksha S
    (2004) Panel reactive antibodies in patients with neoplasia and haematological disorders. Int J Hum Genet 4:147–149.
    OpenUrl
    1. Lee EJ,
    2. Schiffer CA
    (1987) Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients. Blood 70:1727–1729.
    OpenUrlAbstract/FREE Full Text
    1. Pereira J,
    2. Bronfman L,
    3. Bertín P,
    4. Marzouka E,
    5. Hidalgo P,
    6. Amaya S,
    7. et al.
    (1997) [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children]. Rev Med Chil 125:1305–1312, Spanish.
    OpenUrlPubMed
    1. Bordin J,
    2. Heddle N,
    3. Blajchman M
    (1994) Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1703–1721.
    OpenUrlAbstract/FREE Full Text
    1. McGrath K,
    2. Wolf M,
    3. Bishop J,
    4. Veale M,
    5. Ayberk H,
    6. Szer J,
    7. et al.
    (1988) Transient platelet and HLA antibody formation in multitransfused patients with malignancy. Br J Haematol 68:345–350.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section